Total Payments
$1.5M
2024 Payments
$13,177
Companies
34
Transactions
2,068
Payment Breakdown by Category
Other$1.1M (70.7%)
Travel$273,200 (17.7%)
Consulting$127,044 (8.2%)
Food & Beverage$36,191 (2.3%)
Research$15,204 (1.0%)
Education$523.58 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 355 | 69.8% |
| Travel and Lodging | $273,200 | 1,015 | 17.7% |
| Consulting Fee | $127,044 | 56 | 8.2% |
| Food and Beverage | $36,191 | 596 | 2.3% |
| Unspecified | $15,204 | 11 | 1.0% |
| Honoraria | $13,666 | 4 | 0.9% |
| Education | $523.58 | 31 | 0.0% |
Payments by Type
General
$1.5M
2,057 transactions
Research
$15,204
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $647,716 | 901 | $0 (2022) |
| Amgen Inc. | $267,149 | 430 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $197,415 | 172 | $0 (2022) |
| Esperion Therapeutics, Inc. | $116,295 | 108 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $51,864 | 79 | $0 (2024) |
| Amryt Pharma Holdings Ltd | $51,475 | 40 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $39,498 | 55 | $0 (2023) |
| Kaneka Pharma America LLC | $31,463 | 5 | $0 (2021) |
| Novo Nordisk Inc | $26,620 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20,263 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,177 | 65 | Madrigal Pharmaceuticals ($5,907) |
| 2023 | $87,809 | 122 | Amgen Inc. ($34,872) |
| 2022 | $65,671 | 104 | Amgen Inc. ($38,417) |
| 2021 | $138,784 | 128 | Esperion Therapeutics, Inc. ($84,359) |
| 2020 | $95,749 | 106 | Amarin Pharma Inc. ($38,507) |
| 2019 | $231,900 | 407 | Amarin Pharma Inc. ($194,568) |
| 2018 | $390,585 | 525 | Amarin Pharma Inc. ($215,081) |
| 2017 | $521,233 | 611 | Amarin Pharma Inc. ($186,378) |
All Payment Transactions
2,068 individual payment records from CMS Open Payments — Page 1 of 83
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $980.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $78.84 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $55.65 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $32.46 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $24.35 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $6.96 | General |
| 12/09/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $242.02 | General |
| 12/09/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $110.75 | General |
| 12/04/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $787.15 | General |
| 12/04/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 12/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.30 | General |
| 11/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $69.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/17/2024 | Regeneron Pharmaceuticals, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $43.54 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/17/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $37.77 | General |
| 10/30/2024 | Chiesi USA, Inc. | JUXTAPID (Drug) | Food and Beverage | Cash or cash equivalent | $33.19 | General |
| Category: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | ||||||
| 10/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Endocrinology | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,430.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $556.45 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $254.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $186.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $94.62 | General |
| Category: LIVER DISEASE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect of AMR101 on Cardiovascular Heath and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardio | Amarin Pharma Inc. | $12,150 | 4 |
| A THREE-PART, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF EVINACUMAB IN PEDIATRIC PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | Regeneron Pharmaceuticals, Inc. | $3,054 | 7 |
About Dr. Eliot Brinton, MD
Dr. Eliot Brinton, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033209614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eliot Brinton, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $13,177 received in 2024. These payments were reported across 2,068 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.1M).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Salt Lake City, UT
- Active Since 10/13/2006
- Last Updated 02/06/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1033209614
Products in Payments
- Vascepa (Drug) $635,566
- Repatha (Biological) $267,127
- Livalo (Drug) $185,607
- NEXLIZET (Drug) $107,743
- Juxtapid (Drug) $45,033
- PRALUENT (Drug) $35,850
- LIPOSORBER (Device) $31,067
- PRALUENT ALIROCUMAB INJECTION (Biological) $30,378
- EVKEEZA (Biological) $24,491
- JARDIANCE (Drug) $22,933
- Saxenda (Drug) $22,127
- AMR101 (Drug) $12,150
- Kanuma (Drug) $9,283
- NEXLETOL (Drug) $8,551
- PRALUENT (Biological) $8,361
- JUXTAPID (Drug) $7,925
- JANUVIA (Drug) $7,363
- LEQVIO (Drug) $7,289
- REZDIFFRA (Drug) $5,887
- KYNAMRO (Drug) $4,666
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Salt Lake City
Dr. Alireza Falahati-Nini, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $214,560
Endocrinology, Diabetes & Metabolism $214,560
Shahzad Ahmad, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $38,309
Endocrinology, Diabetes & Metabolism $38,309
Barry Benowitz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $27,792
Endocrinology, Diabetes & Metabolism $27,792
Dr. Debra Simmons, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,409
Endocrinology, Diabetes & Metabolism $11,409
Bruce Brady, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $9,030
Endocrinology, Diabetes & Metabolism $9,030
Marie Couldwell
Endocrinology, Diabetes & Metabolism — Payments: $5,078
Endocrinology, Diabetes & Metabolism $5,078